Tumour-Infiltrating Clonal Haematopoiesis Increases the Risk of Recurrence or Death Among Patients with NSCLC and the Risk of Death From Any Cause Among Patients with Solid Tumours By Ogkologos - May 7, 2025 491 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the analysis of TRACERx and MSK-IMPACT studies Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR Easing Concerns about Giving Research Study Participants Their Genetic Test Results June 1, 2018 Trial Highlights Complexities of Targeted Therapy for Pancreatic Cancer June 26, 2019 The RAD51-IF Test Is Feasible for Assessment of the Functional Status... May 7, 2021 School Teacher’s Breast Cancer Journey Inspired Her to Move to Australia... February 17, 2020 Load more HOT NEWS FDA Approves Pralsetinib for Non-Small Cell Lung Cancer with RET Gene... The Childhood Cancer Data Initiative: Why Data Sharing Is Essential to... Loss of Y Chromosome in Men Makes Bladder Cancer More Aggressive Longer Follow-Up Continues to Support First-Line Pembrolizumab Plus Chemotherapy in Metastatic...
